BioCentury | Sep 22, 2014
Finance

Caught short

...$23,200 Synta Pharmaceuticals Corp. (NASDAQ:SNTA) 1/8/10 $28.8 $308,417 Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) 1/22/10 $24.6 $64,007 Somaxon Pharmaceuticals Inc....
BioCentury | Jun 10, 2013
Company News

Trius management update

...general counsel and secretary, a newly created position, formerly SVP, general counsel and secretary of Somaxon Pharmaceuticals Inc....
BioCentury | Jun 3, 2013
Regulation

Suvorexant safety

...letter other than that it did not request additional preclinical or clinical studies. FDA approved Somaxon Pharmaceuticals Inc....
...a generic to treat depression and anxiety. Pernix Therapeutics Holdings Inc. completed its acquisition of Somaxon...
BioCentury | May 13, 2013
Company News

Paladin, Pernix Therapeutics sales and marketing update

...morning awakenings. Health Canada approved the low-dose tricyclic doxepin in late last year. In 2011, Somaxon Pharmaceuticals Inc....
...marketed in the U.S. to treat insomnia characterized by difficulty with sleep maintenance. Pernix acquired Somaxon...
BioCentury | Apr 1, 2013
Company News

Prothena management update

...of Sonexa Therapeutics Inc. ; and Tran Nguyen as CFO, formerly SVP and CFO of Somaxon Pharmaceuticals Inc....
BioCentury | Mar 25, 2013
Company News

Apricus Biosciences management update

...Drug delivery, Genitourinary, Cancer Hired: Richard Pascoe as CEO and a director, formerly CEO of Somaxon Pharmaceuticals Inc....
BioCentury | Mar 11, 2013
Company News

Pernix Therapeutics, Somaxon deal

...Specialty pharma Pernix completed its acquisition of Somaxon in a stock deal that values Somaxon at...
...$25 million (see BioCentury, Dec. 17, 2012). Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), The Woodlands, Texas Somaxon Pharmaceuticals Inc....
BioCentury | Feb 18, 2013
Company News

Somaxon, Actavis neurology news

...of a third party's generic version of Silenor and a final court decision. In 2011, Somaxon...
...mg Silenor infringed U.S. Patent Nos. 6,211,229 and 7,915,307. The '229 patent covers 0.5-20 mg Somaxon...
...deal, Somaxon will make payments to Actavis in recognition of the costs and burden that Somaxon...
BioCentury | Dec 24, 2012
Clinical News

Silenor doxepin regulatory update

...early morning awakenings. Paladin plans to launch the low-dose tricyclic doxepin in mid-2013. Last year, Somaxon...
...with sleep maintenance. Specialty pharma Pernix Therapeutics Holdings Inc. (NYSE-M:PTX, the Woodlands, Texas) is acquiring Somaxon...
...at $25 million. The deal is expected to close next quarter (see BioCentury, Dec. 17). Somaxon Pharmaceuticals Inc....
BioCentury | Dec 17, 2012
Finance

Highlights of weekly biotech stock moves

...two-year deal, BMS will receive $115 million up front, plus tiered royalties (see B8) . Somaxon Pharmaceuticals Inc....
...80%) to $2.65 on Tuesday after Pernix Therapeutics Holdings Inc. (NYSE-M:PTX) said it would acquire Somaxon...
...million. The price of the deal is expected to be $6-$9 per share. Last week, Somaxon...
Items per page:
1 - 10 of 206
BioCentury | Sep 22, 2014
Finance

Caught short

...$23,200 Synta Pharmaceuticals Corp. (NASDAQ:SNTA) 1/8/10 $28.8 $308,417 Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) 1/22/10 $24.6 $64,007 Somaxon Pharmaceuticals Inc....
BioCentury | Jun 10, 2013
Company News

Trius management update

...general counsel and secretary, a newly created position, formerly SVP, general counsel and secretary of Somaxon Pharmaceuticals Inc....
BioCentury | Jun 3, 2013
Regulation

Suvorexant safety

...letter other than that it did not request additional preclinical or clinical studies. FDA approved Somaxon Pharmaceuticals Inc....
...a generic to treat depression and anxiety. Pernix Therapeutics Holdings Inc. completed its acquisition of Somaxon...
BioCentury | May 13, 2013
Company News

Paladin, Pernix Therapeutics sales and marketing update

...morning awakenings. Health Canada approved the low-dose tricyclic doxepin in late last year. In 2011, Somaxon Pharmaceuticals Inc....
...marketed in the U.S. to treat insomnia characterized by difficulty with sleep maintenance. Pernix acquired Somaxon...
BioCentury | Apr 1, 2013
Company News

Prothena management update

...of Sonexa Therapeutics Inc. ; and Tran Nguyen as CFO, formerly SVP and CFO of Somaxon Pharmaceuticals Inc....
BioCentury | Mar 25, 2013
Company News

Apricus Biosciences management update

...Drug delivery, Genitourinary, Cancer Hired: Richard Pascoe as CEO and a director, formerly CEO of Somaxon Pharmaceuticals Inc....
BioCentury | Mar 11, 2013
Company News

Pernix Therapeutics, Somaxon deal

...Specialty pharma Pernix completed its acquisition of Somaxon in a stock deal that values Somaxon at...
...$25 million (see BioCentury, Dec. 17, 2012). Pernix Therapeutics Holdings Inc. (NASDAQ:PTX), The Woodlands, Texas Somaxon Pharmaceuticals Inc....
BioCentury | Feb 18, 2013
Company News

Somaxon, Actavis neurology news

...of a third party's generic version of Silenor and a final court decision. In 2011, Somaxon...
...mg Silenor infringed U.S. Patent Nos. 6,211,229 and 7,915,307. The '229 patent covers 0.5-20 mg Somaxon...
...deal, Somaxon will make payments to Actavis in recognition of the costs and burden that Somaxon...
BioCentury | Dec 24, 2012
Clinical News

Silenor doxepin regulatory update

...early morning awakenings. Paladin plans to launch the low-dose tricyclic doxepin in mid-2013. Last year, Somaxon...
...with sleep maintenance. Specialty pharma Pernix Therapeutics Holdings Inc. (NYSE-M:PTX, the Woodlands, Texas) is acquiring Somaxon...
...at $25 million. The deal is expected to close next quarter (see BioCentury, Dec. 17). Somaxon Pharmaceuticals Inc....
BioCentury | Dec 17, 2012
Finance

Highlights of weekly biotech stock moves

...two-year deal, BMS will receive $115 million up front, plus tiered royalties (see B8) . Somaxon Pharmaceuticals Inc....
...80%) to $2.65 on Tuesday after Pernix Therapeutics Holdings Inc. (NYSE-M:PTX) said it would acquire Somaxon...
...million. The price of the deal is expected to be $6-$9 per share. Last week, Somaxon...
Items per page:
1 - 10 of 206